Sugiyama Waichi

From WikiMD's Food, Medicine & Wellness Encyclopedia

Sugiyama-Waichi-1610-1694

Sugiyama Waichi (1614–1694) was a renowned Japanese acupuncturist and physician during the Edo period. He is best known for his significant contributions to the field of acupuncture and for developing a standardized method of acupuncture needle insertion that greatly improved the practice.

Early Life[edit | edit source]

Sugiyama Waichi was born in 1614 in Japan. Little is known about his early life, but it is believed that he lost his sight at a young age. Despite his blindness, Sugiyama pursued a career in medicine, focusing on acupuncture, which was a prominent form of treatment in Japan during that time.

Contributions to Acupuncture[edit | edit source]

Sugiyama Waichi is credited with inventing the insertion tube, a device that revolutionized the practice of acupuncture. The insertion tube, also known as the guide tube, allowed for more precise and less painful needle insertion. This innovation made acupuncture more accessible and acceptable to a broader range of patients.

Insertion Tube[edit | edit source]

The insertion tube is a small, hollow tube through which the acupuncture needle is inserted. By using this tube, practitioners could stabilize the needle and control its depth more effectively. This method reduced the discomfort associated with needle insertion and minimized the risk of injury.

Legacy[edit | edit source]

Sugiyama Waichi's contributions to acupuncture had a lasting impact on the practice. His techniques are still used today and have influenced modern acupuncture methods. In recognition of his work, Sugiyama is often referred to as the "Father of Japanese Acupuncture."

See Also[edit | edit source]

References[edit | edit source]

Further Reading[edit | edit source]

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD